[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-373473-105":59,"doc-detail-373473-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","medical-treatment-cost-for-chinese-inpatients-with-colorectal-cancer-by-sites","Medical treatment cost for Chinese inpatients with colorectal cancer by sites","","Increasing colorectal cancer prevalence challenges China’s healthcare system. Using Ningbo, China hospitalization data, this retrospective observational study estimates medical treatment costs and cost structure for colorectal cancer by tumor sites, focusing on cost efficiency related to early diagnosis. Inpatients aged over 18 receiving surgical treatment from 2020–2022 were analyzed, with costs categorized and measured in 2020 Chinese Yuan. Rectal cancer costs rose significantly from Stage I to IV, while medication, materials, and examinations dominated overall expenditures.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/medical-treatment-cost-for-chinese-inpatients-with-colorectal-cancer-by-sites/373473/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/medical-treatment-cost-for-chinese-inpatients-with-colorectal-cancer-by-sites/373473.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study aim regarding colorectal cancer costs?","Question",{"text":112,"@type":113},"To estimate medical treatment costs and their structure for colorectal cancer by tumor sites, using Ningbo hospitalization data, to inform insights on early-diagnosis cost efficiency.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study designed and what population was included?",{"text":117,"@type":113},"A retrospective observational study in a tertiary hospital in Ningbo, analyzing inpatients over 18 diagnosed with colorectal cancer who received surgical treatment between 2020 and 2022.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cost components contributed most to overall colorectal cancer medical expenses?",{"text":121,"@type":113},"Medication, materials, and examinations were the major cost sources for both rectal and colon cancers, each accounting for roughly 20% to 30% of total costs depending on site and stage.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},373473,1790578690,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Original Research PUBLISHED 11 June 2025  \nDOI 10. 3389/fpubh.2025.1605887  \nOPEN ACCESS  \nEDITED BY  \nAlessandro Passardi,  \nScientific Institute of Romagna for the Study and Treatment of Tumors (IRCCS), Italy  \nREVIEWED BY  \nZsuzsanna Kívés, University of Pécs, Hungary Nazim Bhimani,  \nRoyal North Shore Hospital, Australia  \n*CORRESPONDENCE  \nJian-Jiong Li  \n [huameileejjone@163.com](huameileejjone@163.com)[ ](huameileejjone@163.com)Yi Lin  \n [lily.lin@nottingham.edu.cn](lily.lin@nottingham.edu.cn)  \nRECEIVED 04 April 2025  \nACCEPTED 21 May 2025  \nPUBLISHED 11 June 2025  \nCITATION  \nHu Z-B, Huang J-Y, McDonald S, Chen B-X, Mao H-X, Wu Z, Dai X-Y, Yu H, Li J-J and Lin Y (2025) Medical treatment cost for Chinese inpatients with colorectal cancer by sites. Front. Public Health 13:1605887 .  \ndoi: 10.3389/fpubh.2025.1605887  \nCOPYRIGHT  \n© 2025 Hu, Huang, McDonald, Chen, Mao, Wu, Dai, Yu, Li and Lin. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMedical treatment cost for Chinese inpatients with colorectal cancer by sites  \nZeng-Bao Hu1 , Jin-Ying Huang2 , Stuart McDonald1 ,  \nBo-Xu Chen3 , Hao-Xun Mao3 , Zhou Wu3 , Xiao-Yu Dai3 , Hua Yu4 , Jian-Jiong Li3* and Yi Lin1*  \n1 Faculty of Humanities and Social Sciences, University of Nottingham Ningbo China, Ningbo, Zhejiang, China, 2 College of International Economics and Trade, Ningbo University of Finance and Economics, Ningbo, Zhejiang, China, 3 Department of Colorectal and Anal Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China, 4 Department of Clinical Nutrition, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China  \nBackground: The increasing prevalence of colorectal cancer (CRC) is a challenge for China’s healthcare system. Using hospitalization data from Ningbo, China, this study aims to estimate the medical treatment cost and cost structure of CRC based on tumor sites to gain insights with respect to the cost e􀀈ciency of early diagnosis.  \nMethods: A retrospective observational study was performed in a real-life clinical setting of a tertiary hospital in Ningbo, China. Sociodemographic, clinicopathologic, and CRC medical treatment cost data were extracted from the inpatients’ medical records. The study comprised inpatients aged above 18 diagnosed with CRC and received surgical treatment between 2020 and 2022 . CRC costs were separated into six cost categories and analyzed separately by tumor site (rectum and colon) . All cost data were measured by 2020 Chinese Yuan.  \nResults: A total of 538 inpatients were included, where 63 .9% were male, 67 . 5% were diagnosed with rectal cancer, and 47 . 2% were at Stages III and IV. Medical treatment costs of rectal cancer increased significantly from Stage I to Stage IV in all cost categories (p \u003C 0.001), with percentage increases ranging from 70% to 120%, depending on cost category. Medication, materials, and examinations were the major sources of CRC costs for both rectal and colon cancers, with each accounting for 20%􀀀30% of total costs, depending on tumor site and cancer stage.  \nConclusions: Targeted programs for the management and treatment of various tumor sites should be considered, as rectal cancer costs are more stage-sensitive than colon cancer. The large proportion of costs attributed to medication, materials, and examinations provides guidance to the government in regulating the healthcare market to alleviate the economic burden of CRC.  \nKEYWORDS  \nChina, colorectal cancer, medical costs, economic burden, stage at diagnosis  \n1 Introduction  \nColorectal cancer (CRC) is the third most common cancer and the second leadin","cbCaikKrDgmnY653","https://ap.wps.com/l/cbCaikKrDgmnY653","pdf",593571,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What was the study aim regarding colorectal cancer costs?\",\"answer\":\"To estimate medical treatment costs and their structure for colorectal cancer by tumor sites, using Ningbo hospitalization data, to inform insights on early-diagnosis cost efficiency.\"},{\"question\":\"How was the study designed and what population was included?\",\"answer\":\"A retrospective observational study in a tertiary hospital in Ningbo, analyzing inpatients over 18 diagnosed with colorectal cancer who received surgical treatment between 2020 and 2022.\"},{\"question\":\"Which cost components contributed most to overall colorectal cancer medical expenses?\",\"answer\":\"Medication, materials, and examinations were the major cost sources for both rectal and colon cancers, each accounting for roughly 20% to 30% of total costs depending on site and stage.\"}]","Medical treatment cost for Chinese inpatients with colorectal cancer by sites | PDF",1790199660,23]